{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:43:05Z","timestamp":1785307385764,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.bpg.2018.09.001","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:03:35Z","timestamp":1536681815000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["PBC-transplantation and disease recurrence"],"prefix":"10.1016","volume":"34-35","author":[{"given":"Frederik","family":"Nevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2018.09.001_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.bpg.2018.09.001_bib2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","author":"Carbone","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.bpg.2018.09.001_bib3","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2018.09.001_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cgh.2017.09.062","article-title":"Twenty-year comparative analysis of patients with autoimmune liver diseases on transplant waitlists","volume":"16","author":"Webb","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4S Suppl 2","key":"10.1016\/j.bpg.2018.09.001_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001651","article-title":"Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the consensus on managing modifiable risk in transplantation (COMMIT) group","volume":"101","author":"Neuberger","year":"2017","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.bpg.2018.09.001_bib6","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/TP.0000000000001631","article-title":"Adult liver allocation in eurotransplant","volume":"101","author":"Jochmans","year":"2017","journal-title":"Transplantation"},{"issue":"21","key":"10.1016\/j.bpg.2018.09.001_bib7","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.3748\/wjg.14.3313","article-title":"Clinical features and management of primary biliary cirrhosis","volume":"14","author":"Crosignani","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.bpg.2018.09.001_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cld.2008.02.012","article-title":"Natural history of primary biliary cirrhosis","volume":"12","author":"Mayo","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.bpg.2018.09.001_bib9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.25847","article-title":"Pathogenesis of cholestatic itch: old questions, new answers, and future opportunities","volume":"56","author":"Jones","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bpg.2018.09.001_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"The diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"EASL Clinical Practice Guidelines","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2018.09.001_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/gut.49.2.276","article-title":"Dutch Multicentre PBC study group. Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant","volume":"49","author":"Vleggaar","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2018.09.001_bib12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep.510290229","article-title":"Quality of life before and after liver transplantation for cholestatic liver disease","volume":"29","author":"Gross","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.09.001_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jhep.2013.02.019","article-title":"The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC research cohort","volume":"59","author":"Pells","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2018.09.001_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary cirrhosis","volume":"20","author":"Shapiro","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2018.09.001_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study","volume":"65","author":"Trivedi","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2018.09.001_bib16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.22458","article-title":"Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis","volume":"48","author":"Silveira","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.09.001_bib17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/hep.23095","article-title":"Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers","volume":"50","author":"Cavazza","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.09.001_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"44","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2018.09.001_bib19","doi-asserted-by":"crossref","first-page":"S798","DOI":"10.1016\/S0168-8278(15)31380-5","article-title":"Age, bilirubin and albumin, regardless of sex, are the strongest independent predictors of biochemical response and transplantation-free survival in patients with primary biliary cirrhosis","volume":"62","author":"Cheung","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.bpg.2018.09.001_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cgh.2011.09.013","article-title":"Long-term outcomes of patients with primary biliary cirrhosis and hepatocellular carcinoma","volume":"10","author":"Imam","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.bpg.2018.09.001_bib21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ajg.2017.440","article-title":"Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: risk factors and time trends in incidence and outcome","volume":"113","author":"Harms","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2018.09.001_bib22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cirrhosis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bpg.2018.09.001_bib23","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.1840150518","article-title":"Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?","volume":"15","author":"Crippin","year":"1992","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bpg.2018.09.001_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/gut.51.2.265","article-title":"Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis","volume":"51","author":"Longo","year":"2002","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.bpg.2018.09.001_bib25","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1136\/gut.2005.079814","article-title":"Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis","volume":"55","author":"Allocca","year":"2006","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.bpg.2018.09.001_bib26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/hepr.12452","article-title":"Coronary artery disease in primary biliary cirrhosis: a systematic review and meta-analysis of observational studies","volume":"45","author":"Ungprasert","year":"2014","journal-title":"Hepatol Res"},{"issue":"6","key":"10.1016\/j.bpg.2018.09.001_bib27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jhep.2009.03.005","article-title":"Vitamin D receptor polymorphisms in primary biliary cirrhosis: a functional connection?","volume":"50","author":"Adorini","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2018.09.001_bib28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00535-013-0782-5","article-title":"Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system","volume":"49","author":"Genda","year":"2014","journal-title":"J\u00a0Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2018.09.001_bib29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/tri.12877","article-title":"Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation","volume":"30","author":"Singal","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.bpg.2018.09.001_bib30","series-title":"Waitlist mortality and post-transplant survival in patients with cholestatic liver disease - impact of changes in allocation policy","author":"Staufer","year":"2018"},{"key":"10.1016\/j.bpg.2018.09.001_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","article-title":"Evolving frequency and outcomes of liver transplantation based on etiology of liver disease","volume":"95","author":"Singal","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2018.09.001_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the european liver transplant registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2018.09.001_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ajg.2016.10","article-title":"De novo malignancy and recurrent alcoholic cirrhosis account for 70% of deaths in patients transplanted for end-stage alcoholic liver disease","volume":"111","author":"Verbeek","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2018.09.001_bib34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00007890-199602270-00007","article-title":"The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation","volume":"61","author":"Berlakovich","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2018.09.001_bib35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/lt.500040313","article-title":"Allograft rejection after liver transplantation for autoimmune liver diseases","volume":"4","author":"Hayashi","year":"1998","journal-title":"Liver Transplant Surg"},{"key":"10.1016\/j.bpg.2018.09.001_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200008150-00014","article-title":"Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors","volume":"70","author":"Milkiewicz","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2018.09.001_bib37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0012.2007.00788.x","article-title":"Late acute rejection after liver transplantation impacts patient survival","volume":"22","author":"Uemura","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bpg.2018.09.001_bib38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/TP.0b013e3182845f6c","article-title":"Late acute liver allograft rejection; a study of its natural history and graft survival in the current era","volume":"95","author":"Thurairajah","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2018.09.001_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bpg.2018.09.001_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jlts.2003.36392","article-title":"Liver transplantation for primary biliary cirrhosis: a long-term pathologic study","volume":"9","author":"Khettry","year":"2003","journal-title":"Liver Transplant"},{"issue":"10","key":"10.1016\/j.bpg.2018.09.001_bib41","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transplant"},{"issue":"11","key":"10.1016\/j.bpg.2018.09.001_bib42","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.bpg.2018.09.001_bib43","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.bpg.2018.09.001_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bpg.2018.09.001_bib45","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.bpg.2018.09.001_bib46","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.bpg.2018.09.001_bib47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/lt.21960","article-title":"Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity","volume":"16","author":"Manousou","year":"2010","journal-title":"Liver Transplant"},{"key":"10.1016\/j.bpg.2018.09.001_bib48","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/ajt.12132","article-title":"Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Carbone","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpg.2018.09.001_bib49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bpg.2018.09.001_bib50","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ajt.13583","article-title":"Long-term outcomes of living-donor liver transplantation for primary biliary cirrhosis: a Japanese multicenter study","volume":"16","author":"Egawa","year":"2016","journal-title":"Am J Transplant"},{"issue":"22","key":"10.1016\/j.bpg.2018.09.001_bib51","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A\u00a0multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC study group","volume":"324","author":"Poupon","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.bpg.2018.09.001_bib52","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A\u00a0placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpg.2018.09.001_bib53","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.20511","article-title":"Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant","volume":"11","author":"Guy","year":"2005","journal-title":"Liver Transplant"},{"issue":"6","key":"10.1016\/j.bpg.2018.09.001_bib54","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2018.09.001_bib55","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Silveira","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpg.2018.09.001_bib56","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/lt.23742","article-title":"Systematic investigation of elevated cholestatic enzymes during the third posttransplant month","volume":"19","author":"Mason","year":"2013","journal-title":"Liver Transplant"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691818300854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691818300854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:01:24Z","timestamp":1761498084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691818300854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":56,"alternative-id":["S1521691818300854"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2018.09.001","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PBC-transplantation and disease recurrence","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2018.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}